Ionis Pharmaceuticals, Inc.
IONS · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $944M | $705M | +33.8% |
| Operating income | −$382M | −$475M | +19.7% |
| Net income | −$381M | −$454M | +16.0% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $243M | $157M | +54.9% |
| Operating income | −$131M | −$160M | +18.4% |
| Net income | −$110M | −$129M | +14.5% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Ionis's revenue in FY2025?
- $944M in FY2025 (Fiscal year ended Dec 31, 2025), +33.8% vs $705M a year earlier, per its 10-K filed Feb 2026.
- Was Ionis profitable in FY2025?
- No: net income was −$381M and operating income −$382M in FY2025.
- What was Ionis's revenue in Q3 2026?
- $243M (+54.9% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.